BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7282751)

  • 1. Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol.
    Maschio G; Tessitore N; D'Angelo A; Fabris A; Pagano F; Tasca A; Graziani G; Aroldi A; Surian M; Colussi G; Mandressi A; Trinchieri A; Rocco F; Ponticelli C; Minetti L
    Am J Med; 1981 Oct; 71(4):623-6. PubMed ID: 7282751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive medical treatment of recurrent urinary calcium calculi].
    François B; Trolliet P; Cahen R; Semet MP
    Nephrologie; 1986; 7(1):9-12. PubMed ID: 3960261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
    Coe FL
    Ann Intern Med; 1977 Oct; 87(4):404-10. PubMed ID: 907239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts.
    Leppla D; Browne R; Hill K; Pak CY
    J Clin Endocrinol Metab; 1983 Nov; 57(5):920-4. PubMed ID: 6619267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Crystalluria during prophylactic treatment of urinary lithiasis with allopurinol, hydrochlorothiazide, manganese oxide, diphosphonates and propionohydroxamic acid].
    Buli P; Brunocilla E; Tiozzi E; Platania A; Cortecchia V
    Nephrologie; 1984; 5(5):213-6. PubMed ID: 6531058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of idiopathic calcium nephrolithiasis.
    Surian M; Malberti F; Colussi G; De Ferrari ME; Rombolà G; Benazzi E; Minetti L
    Contrib Nephrol; 1987; 58():172-5. PubMed ID: 3691120
    [No Abstract]   [Full Text] [Related]  

  • 7. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?
    Vigen R; Weideman RA; Reilly RF
    Int Urol Nephrol; 2011 Sep; 43(3):813-9. PubMed ID: 20737209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
    Arowojolu O; Goldfarb DS
    J Nephrol; 2014 Dec; 27(6):601-5. PubMed ID: 24687403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-uric acid nephrolithiasis.
    Coe FL
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium lithiasis: uric acid under question].
    Petit C
    Nephrologie; 1984; 5(5):192-4. PubMed ID: 6531055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers and uric-acid excretion.
    Pedersen OL; Mikkelsen E
    Lancet; 1978 Nov; 2(8100):1160. PubMed ID: 82728
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
    Dhayat NA; Faller N; Bonny O; Mohebbi N; Ritter A; Pellegrini L; Bedino G; Schönholzer C; Venzin RM; Hüsler C; Koneth I; Del Giorno R; Gabutti L; Amico P; Mayr M; Odermatt U; Buchkremer F; Ernandez T; Stoermann-Chopard C; Teta D; Rintelen F; Roumet M; Irincheeva I; Trelle S; Tamò L; Roth B; Vogt B; Fuster DG
    BMC Nephrol; 2018 Dec; 19(1):349. PubMed ID: 30526528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of thiazide-induced hypokalemia to amiloride.
    Maronde RF; Milgrom M; Vlachakis ND; Chan L
    JAMA; 1983 Jan; 249(2):237-41. PubMed ID: 6848810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of renal excretion of uric acid during long-term thiazide therapy.
    Pak CY; Tolentino R; Stewart A; Galosy RA
    Invest Urol; 1978 Nov; 16(3):191-3. PubMed ID: 711411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazide.
    Spence JD; Wong DG; Lindsay RM
    Lancet; 1985 Jul; 2(8446):73-5. PubMed ID: 2861527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fixed combination of hydrochlorothiazide and amiloride for the treatment of essential hypertension.
    Ruilope L; Alcazar JM; Diaz VP; Jarillo MD; Millet VG; Rodicio JL
    Clin Ther; 1980; 3(1):15-20. PubMed ID: 7407819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological basis for a fixed association of hydrochlorothiazide, amiloride hydrochloride, and timolol maleate (author's transl)].
    Safar M; Tzincoca C
    Sem Hop; 1979 Jun 8-15; 55(21-22):1095-9. PubMed ID: 225816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.